Valuation : BioNTech SE

Market Cap 22.5B 26.08B 21.19B 19.31B 36.09B 2,463B 36.36B 251B 97.37B 1,259B 97.92B 95.78B 4,137B P/E 2026 *
-15.9x
P/E 2027 * -17.3x
Enterprise Value 11.13B 12.9B 10.48B 9.55B 17.85B 1,219B 17.99B 124B 48.17B 623B 48.44B 47.38B 2,047B EV / Sales 2026 *
6.16x
EV / Sales 2027 * 6.88x
Free-Float
96.06%
Yield 2026 *
-
Yield 2027 * -
1 day-1.00%
1 week-7.92%
Current month+0.95%
1 month+11.20%
3 months+15.98%
6 months+1.81%
Current year+7.75%
1 week 98.8
Extreme 98.8
105.46
1 month 88.2
Extreme 88.2
120.33
Current year 79.52
Extreme 79.52
124
1 year 79.52
Extreme 79.52
124
3 years 76.53
Extreme 76.5301
131.49
5 years 76.53
Extreme 76.5301
374.85
10 years 12.52
Extreme 12.525
464
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2018
Chief Executive Officer 61 02/06/2008
Director of Finance/CFO - 01/07/2025
Director TitleAgeSince
Chairman 56 02/06/2008
Director/Board Member 69 02/06/2008
Director/Board Member 65 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
12/5/26 Free

Chief Operating Officer

22,655 0.0094%
12/5/26 Free

Chief Financial Officer

33,982 0.0141%
12/5/26 Free

Head of Human Resources

18,879 0.0078%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-7.92%+2.15%-15.92% 26.08B
+1.03%-2.05%+39.28%+94.60% 68.87B
+1.31%+0.55%+49.48%+92.12% 65.29B
-0.32%+4.01%-12.01%+378.80% 27.65B
+2.97%-0.10%+41.86%+14.84% 25.77B
+1.01%+1.38%+26.48%-17.50% 20.14B
+3.45%-14.83%+225.22%+389.50% 17.03B
+0.77%-4.55%-0.36%+549.41% 15.03B
+1.08%+7.18%+60.25%+165.96% 14.5B
-0.40%+0.54%+25.58%+196.28% 12.64B
Average +0.99%-2.24%+45.79%+184.81% 29.3B
Weighted average by Cap. +1.02%-1.97%+41.97%+144.69%

Financials

2026 *2027 *
Net sales 1.81B 2.09B 1.7B 1.55B 2.9B 198B 2.92B 20.15B 7.82B 101B 7.86B 7.69B 332B 1.81B 2.1B 1.71B 1.56B 2.91B 199B 2.93B 20.22B 7.85B 101B 7.89B 7.72B 333B
Net income -1.38B -1.6B -1.3B -1.18B -2.21B -151B -2.23B -15.37B -5.96B -77.14B -6B -5.87B -253B -1.31B -1.52B -1.23B -1.12B -2.1B -143B -2.12B -14.59B -5.66B -73.26B -5.7B -5.57B -241B
Net Debt -11.37B -13.18B -10.71B -9.76B -18.24B -1,245B -18.38B -127B -49.21B -636B -49.48B -48.4B -2,091B -10.03B -11.63B -9.45B -8.61B -16.09B -1,098B -16.21B -112B -43.42B -562B -43.66B -42.71B -1,845B
Logo BioNTech SE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Employees
7,807
Date Price Change Volume
03/09/26 US$102.68 -1.09% 243,789
02/09/26 US$103.81 +1.83% 753,654
01/09/26 US$101.95 +0.33% 1,040,116
31/08/26 US$101.61 -0.46% 1,089,897
28/08/26 US$102.08 -8.37% 3,072,881
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
89.56EUR
Average target price
103.61EUR
Spread / Average Target
+15.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BNTX Stock